Impact Factor
3.01
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.55
54 total citations
h5-index
15
h5 depth signal
Cited share
70.0%
14 of 20
Total citations
54
Citation footprint
Metric signal
2.61
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Spain
76
United States
38
China
23
Belgium
10
Italy
9
Citing Fields of Research
HIV
151
Virology
18
Hepatitis
14
Sexually Transmitted Diseases
9
Immunology
9
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
217
Articles tracked across the journal lifetime
Indexed publication set
20
14 cited publications
Last 12 months
103
14.7 publications/month
Open access share
19.4%
20 OA publications in the last year
Leading citing country
Spain
76 citing publications
Leading citing field
HIV
151 citing publications
Latest tracked publication
13 October 2026
10 recent records available
Coverage & Indexing History
v4n1, Jan.-Mar. 2002-
v4n1, Jan.-Mar. 2002-
Active Coverage
Research Focus & Classification
Indexed Subjects
HIV
Broad Categories
Acquired Immunodeficiency Syndrome
HIV
MeSH Descriptors
Acquired Immunodeficiency Syndrome
HIV Infections
Retroviridae
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.24875/aidsrev.m26000097
Open DOI
Will AI soon replace doctors?
The full content will be available shortly. Thank you for your patience!
02
03
04
DOI 10.24875/aidsrev.26000016
Open DOI
Long-acting HIV treatment and prevention: a bibliometric analysis and science mapping
05
DOI 10.24875/aidsrev.26000002
Open DOI
Current challenges in caring for injection drug users with human immunodeficiency virus infection in Pakistan
06
DOI 10.24875/aidsrev.26000001
Open DOI
Improving treatment adherence among people living with HIV through adherence counseling: a scoping review
The full content will be available shortly. Thank you for your patience!
07
DOI 10.24875/aidsrev.26000007
Open DOI
Off-label use of antiretroviral drugs: ethical and legal implications for clinical decision-making
The use of authorized medicinal products under conditions other than those approved, commonly referred to as off-label use, is an increasingly frequent practice in health care. It is particularly relevant in the therapeutic management of...
08
DOI 10.24875/aidsrev.26000004
Open DOI
Systematic review and meta-analysis of risk prediction models for HIV testing in key populations
The full content will be available shortly. Thank you for your patience!
09
DOI 10.24875/aidsrev.m26000096
Open DOI
Hantavirus outbreak in a cruise departing from Argentina
The full content will be available shortly. Thank you for your patience!
10
DOI 10.24875/aidsrev.m26000095
Open DOI
Dolutegravir shows efficacy in HTLV-1 infection
The full content will be available shortly. Thank you for your patience!
Bibliographical & Catalog Notes
Description based on: Vol. 2, no. 1 (Jan.-Mar. 2000); title from cover.
Also issued online.